Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
出版年份 2019 全文链接
标题
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
作者
关键词
-
出版物
MOLECULES
Volume 24, Issue 21, Pages 3835
出版商
MDPI AG
发表日期
2019-10-25
DOI
10.3390/molecules24213835
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension
- (2019) Qing Li et al. BIOCONJUGATE CHEMISTRY
- Fusion with an albumin‐binding domain improves pharmacokinetics of an αvβ3‐integrin binding fibronectin scaffold protein
- (2019) S. Sh. Gapizov et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations
- (2019) Roman V. Kholodenko et al. CURRENT MEDICINAL CHEMISTRY
- Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
- (2018) Haitao Pan et al. International Journal of Nanomedicine
- Tumor uptake of pegylated diabodies: Balancing systemic clearance and vascular transport
- (2018) Qing Li et al. JOURNAL OF CONTROLLED RELEASE
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Neurotoxicity Associated with a High-Affinity GD2 CAR—Letter
- (2018) Robbie G. Majzner et al. Cancer Immunology Research
- The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
- (2018) Katie L. Greenwood et al. Expert Opinion On Drug Safety
- Interleukin 2 plus anti-GD2 immunotherapy: helpful or harmful?
- (2018) Katherine K Matthay LANCET ONCOLOGY
- Protein PEGylation for cancer therapy: bench to bedside
- (2018) Vijayalaxmi Gupta et al. Journal of Cell Communication and Signaling
- Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins
- (2017) Christian Fercher et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Anti-GD2 immunotherapy for neuroblastoma
- (2017) Sameer Sait et al. Expert Review of Anticancer Therapy
- Mechanistic understanding of the cysteine capping modifications of antibodies enables selective chemical engineering in live mammalian cells
- (2017) Xiaotian Zhong et al. JOURNAL OF BIOTECHNOLOGY
- Theranostics Using Antibodies and Antibody-Related Therapeutics
- (2017) Kirsten L. Moek et al. JOURNAL OF NUCLEAR MEDICINE
- Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO
- (2017) Ina Mueller et al. mAbs
- Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy
- (2017) Tatjana Terzic et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis
- (2017) Evgeniya Sokolova et al. Oncotarget
- Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies
- (2017) Eric Sterner et al. Cell Reports
- High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
- (2017) Sarah A. Richman et al. Cancer Immunology Research
- Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy
- (2016) Zulmarie Perez Horta et al. Immunotherapy
- Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2
- (2016) A. A. Zubareva et al. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8
- (2015) Qi Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody
- (2015) Irena Horwacik et al. MOLECULAR & CELLULAR PROTEOMICS
- Ganglioside GD2 in reception and transduction of cell death signal in tumor cells
- (2014) Igor I Doronin et al. BMC CANCER
- Preparation of Fab-Fragments of GD2-Specific Antibodies and Analysis of Their Antitumor Activity In Vitro
- (2013) I. I. Doronin et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- High-Affinity VEGF Antagonists by Oligomerization of a Minimal Sequence VEGF-Binding Domain
- (2012) James E. Stefano et al. BIOCONJUGATE CHEMISTRY
- Modulating antibody pharmacokinetics using hydrophilic polymers
- (2011) Chen Chen et al. Expert Opinion on Drug Delivery
- Anti-GD2 with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia
- (2010) Linda S. Sorkin et al. PAIN
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells
- (2009) Aleksandra Kowalczyk et al. CANCER LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started